

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 4.42403428 |
| 2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.18111160 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.01675516 |
| 4 | response to peptidoglycan (GO:0032494) | 3.79448762 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.78819220 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 3.78100623 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73445223 |
| 8 | response to muramyl dipeptide (GO:0032495) | 3.68637219 |
| 9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63767795 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57549306 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57549306 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 3.51540386 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47541158 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.45095454 |
| 15 | natural killer cell mediated immunity (GO:0002228) | 3.44847650 |
| 16 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.44847650 |
| 17 | tolerance induction (GO:0002507) | 3.43152031 |
| 18 | myeloid dendritic cell differentiation (GO:0043011) | 3.40679490 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.38794664 |
| 20 | cellular response to interferon-beta (GO:0035458) | 3.36287743 |
| 21 | B cell mediated immunity (GO:0019724) | 3.35404020 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.34460750 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34460750 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.34460750 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34460750 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34460750 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34460750 |
| 28 | positive regulation of humoral immune response (GO:0002922) | 3.31995608 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.30923682 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30923682 |
| 31 | cellular response to type I interferon (GO:0071357) | 3.30099974 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.30099974 |
| 33 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.27936018 |
| 34 | positive regulation of interleukin-12 production (GO:0032735) | 3.25454708 |
| 35 | response to type I interferon (GO:0034340) | 3.25427708 |
| 36 | regulation of RIG-I signaling pathway (GO:0039535) | 3.22497938 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19528767 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.18431035 |
| 39 | granulocyte activation (GO:0036230) | 3.16624349 |
| 40 | DNA deamination (GO:0045006) | 3.14338567 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.13831328 |
| 42 | germinal center formation (GO:0002467) | 3.12343738 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 3.10680988 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10460670 |
| 45 | response to interferon-beta (GO:0035456) | 3.09906404 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09742434 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.09692668 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.09168860 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06659174 |
| 50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04738804 |
| 51 | respiratory burst (GO:0045730) | 2.99704648 |
| 52 | positive regulation of isotype switching (GO:0045830) | 2.98935807 |
| 53 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.96865095 |
| 54 | regulation of immunoglobulin secretion (GO:0051023) | 2.96501496 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96484790 |
| 56 | regulation of chronic inflammatory response (GO:0002676) | 2.95728507 |
| 57 | regulation of activation of Janus kinase activity (GO:0010533) | 2.93419116 |
| 58 | neutrophil activation (GO:0042119) | 2.92808255 |
| 59 | defense response to protozoan (GO:0042832) | 2.92520123 |
| 60 | leukocyte mediated cytotoxicity (GO:0001909) | 2.91767099 |
| 61 | cellular response to arsenic-containing substance (GO:0071243) | 2.91749839 |
| 62 | regulation of vitamin metabolic process (GO:0030656) | 2.91311130 |
| 63 | regulation of interleukin-12 production (GO:0032655) | 2.90514913 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.90289846 |
| 65 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.87467300 |
| 66 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87107168 |
| 67 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87107168 |
| 68 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.85187679 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83854904 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.83776842 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 2.83663747 |
| 72 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83521287 |
| 73 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82610728 |
| 74 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.80575468 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 2.79873337 |
| 76 | regulation of T-helper cell differentiation (GO:0045622) | 2.79660087 |
| 77 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.79601280 |
| 78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79491268 |
| 79 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.79129974 |
| 80 | activation of MAPKKK activity (GO:0000185) | 2.78872504 |
| 81 | T cell migration (GO:0072678) | 2.78150449 |
| 82 | positive regulation of interferon-beta production (GO:0032728) | 2.77904943 |
| 83 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77705266 |
| 84 | positive regulation of interleukin-2 production (GO:0032743) | 2.77177440 |
| 85 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77010905 |
| 86 | positive regulation of defense response to virus by host (GO:0002230) | 2.76724334 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76214786 |
| 88 | cellular response to virus (GO:0098586) | 2.76091669 |
| 89 | negative regulation of interleukin-12 production (GO:0032695) | 2.76016924 |
| 90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75499923 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75170763 |
| 92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74352126 |
| 93 | ribosomal small subunit biogenesis (GO:0042274) | 2.73697802 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73503723 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73428135 |
| 96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72018928 |
| 97 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70957394 |
| 98 | negative regulation of viral genome replication (GO:0045071) | 2.70481216 |
| 99 | regulation of B cell apoptotic process (GO:0002902) | 2.70437081 |
| 100 | leukocyte aggregation (GO:0070486) | 2.69770719 |
| 101 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.68779675 |
| 102 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.67473558 |
| 103 | positive regulation of interleukin-17 production (GO:0032740) | 2.67427785 |
| 104 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.66845053 |
| 105 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66663192 |
| 106 | response to protozoan (GO:0001562) | 2.65874032 |
| 107 | negative thymic T cell selection (GO:0045060) | 2.64919611 |
| 108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.64595467 |
| 109 | cellular response to zinc ion (GO:0071294) | 2.64457814 |
| 110 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.63662900 |
| 111 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.63357604 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63262811 |
| 113 | lymphocyte mediated immunity (GO:0002449) | 2.63214348 |
| 114 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.63168403 |
| 115 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.62953083 |
| 116 | amino sugar catabolic process (GO:0046348) | 2.61863409 |
| 117 | dendritic cell differentiation (GO:0097028) | 2.61296650 |
| 118 | T cell apoptotic process (GO:0070231) | 2.60698781 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.60307165 |
| 120 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.59650005 |
| 121 | positive regulation of T cell apoptotic process (GO:0070234) | 2.58754484 |
| 122 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.57032904 |
| 123 | regulation of defense response to virus by host (GO:0050691) | 2.55839003 |
| 124 | regulation of hypersensitivity (GO:0002883) | 2.55347045 |
| 125 | regulation of fever generation (GO:0031620) | 2.54398767 |
| 126 | positive regulation of prostaglandin secretion (GO:0032308) | 2.52546553 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.52258333 |
| 128 | cellular response to nicotine (GO:0071316) | 2.51789336 |
| 129 | T-helper 1 type immune response (GO:0042088) | 2.51748341 |
| 130 | regulation of T-helper 1 type immune response (GO:0002825) | 2.50609557 |
| 131 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.49793905 |
| 132 | monocyte chemotaxis (GO:0002548) | 2.49569072 |
| 133 | positive regulation of heat generation (GO:0031652) | 2.48044380 |
| 134 | positive regulation of protein homooligomerization (GO:0032464) | 2.47675114 |
| 135 | myeloid cell activation involved in immune response (GO:0002275) | 2.47635188 |
| 136 | negative T cell selection (GO:0043383) | 2.47610671 |
| 137 | reactive oxygen species biosynthetic process (GO:1903409) | 2.47342972 |
| 138 | interferon-gamma secretion (GO:0072643) | 2.46237833 |
| 139 | negative regulation of interleukin-1 production (GO:0032692) | 2.46023393 |
| 140 | regulation of interferon-beta production (GO:0032648) | 2.45892720 |
| 141 | positive thymic T cell selection (GO:0045059) | 2.43599867 |
| 142 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42762634 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.42716290 |
| 144 | lymphocyte chemotaxis (GO:0048247) | 2.41973541 |
| 145 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.41593867 |
| 146 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.38880640 |
| 147 | NAD biosynthetic process (GO:0009435) | 2.38094239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26124600 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91347194 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.59550937 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.39014536 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13629189 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.88839172 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67158562 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52631937 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44494573 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.25565614 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22790076 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.18889785 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11427905 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.07805378 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07709838 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03143567 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01551744 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.98183805 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.96607825 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91128423 |
| 21 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.88503842 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.85915572 |
| 23 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.85510412 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85471472 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85111669 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83626244 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83176204 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81945948 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81699331 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81514887 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81196536 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80903616 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.78351220 |
| 34 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77840838 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74465819 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.72809449 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.68179702 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.64471408 |
| 39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63998809 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61721236 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61246871 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60465821 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.60399397 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59305974 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58326923 |
| 46 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56921351 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56890969 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56409123 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55789301 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51061490 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49706349 |
| 52 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49225783 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.47568882 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46767566 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45582605 |
| 56 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.45080896 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44880818 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43676780 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41303725 |
| 60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.41135889 |
| 61 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39970095 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37183571 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35923775 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.35668965 |
| 65 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34306823 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.34279520 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34240937 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33679613 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32807202 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32336437 |
| 71 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.31946232 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.31823576 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31473003 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30836665 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29724810 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29512506 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28804787 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27663998 |
| 79 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27415408 |
| 80 | SA1_27219007_Chip-Seq_Bcells_Human | 1.27250313 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26528288 |
| 82 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24686749 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24308552 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23186115 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23093979 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.22888080 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22802045 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21760835 |
| 89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20463045 |
| 90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19580818 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.18500964 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18479213 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18366754 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17578558 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17304103 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16805008 |
| 97 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15732050 |
| 98 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15011804 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.14623550 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12944107 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12512451 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12396890 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11707833 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10678727 |
| 105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10504643 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10255189 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10038229 |
| 108 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09701939 |
| 109 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09226631 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08683968 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 1.08397134 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08307233 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06933117 |
| 114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06901544 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06642216 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06485031 |
| 117 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05916427 |
| 118 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05401579 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05068526 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05037081 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05021865 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04668466 |
| 123 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04110945 |
| 124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04109152 |
| 125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03566652 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03448816 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03367375 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02898192 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02085992 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01982577 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01478837 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01454158 |
| 133 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01128219 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99242274 |
| 135 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98091280 |
| 136 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94353242 |
| 137 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93516000 |
| 138 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92994523 |
| 139 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.92749610 |
| 140 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.92257530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.32220863 |
| 2 | * MP0009785_altered_susceptibility_to | 3.47567484 |
| 3 | MP0000685_abnormal_immune_system | 3.47081428 |
| 4 | * MP0003436_decreased_susceptibility_to | 3.27219719 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.24257183 |
| 6 | * MP0005000_abnormal_immune_tolerance | 2.95106597 |
| 7 | MP0005671_abnormal_response_to | 2.93831420 |
| 8 | MP0006082_CNS_inflammation | 2.85518814 |
| 9 | MP0001790_abnormal_immune_system | 2.84956157 |
| 10 | MP0005387_immune_system_phenotype | 2.84956157 |
| 11 | * MP0005025_abnormal_response_to | 2.71638353 |
| 12 | MP0003303_peritoneal_inflammation | 2.69473286 |
| 13 | MP0001800_abnormal_humoral_immune | 2.65055938 |
| 14 | MP0004510_myositis | 2.53190512 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.53085136 |
| 16 | * MP0002723_abnormal_immune_serum | 2.49913356 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.46562550 |
| 18 | MP0002419_abnormal_innate_immunity | 2.41939475 |
| 19 | MP0001853_heart_inflammation | 2.31264698 |
| 20 | MP0001819_abnormal_immune_cell | 2.24748583 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.22520293 |
| 22 | MP0003724_increased_susceptibility_to | 2.19457844 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.14321379 |
| 24 | MP0002405_respiratory_system_inflammati | 2.12619125 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.02815617 |
| 26 | MP0001986_abnormal_taste_sensitivity | 2.00163272 |
| 27 | MP0002398_abnormal_bone_marrow | 1.95236741 |
| 28 | MP0000716_abnormal_immune_system | 1.85791563 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.83989108 |
| 30 | MP0009840_abnormal_foam_cell | 1.83151611 |
| 31 | MP0004947_skin_inflammation | 1.82606704 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.76551498 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.74563238 |
| 34 | MP0008057_abnormal_DNA_replication | 1.73312953 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.67749396 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.66612262 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.66612262 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.66355355 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.66296730 |
| 40 | MP0002722_abnormal_immune_system | 1.61315554 |
| 41 | MP0002429_abnormal_blood_cell | 1.61030580 |
| 42 | MP0003186_abnormal_redox_activity | 1.57882261 |
| 43 | MP0009764_decreased_sensitivity_to | 1.56862574 |
| 44 | MP0000858_altered_metastatic_potential | 1.55105506 |
| 45 | MP0005310_abnormal_salivary_gland | 1.54032380 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.53976066 |
| 47 | * MP0008469_abnormal_protein_level | 1.53276843 |
| 48 | * MP0001533_abnormal_skeleton_physiology | 1.46784767 |
| 49 | MP0003448_altered_tumor_morphology | 1.40542185 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.39121619 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.37350260 |
| 52 | MP0002006_tumorigenesis | 1.35840433 |
| 53 | MP0003077_abnormal_cell_cycle | 1.35610053 |
| 54 | MP0005410_abnormal_fertilization | 1.30684207 |
| 55 | MP0002163_abnormal_gland_morphology | 1.29229241 |
| 56 | MP0000490_abnormal_crypts_of | 1.28264172 |
| 57 | MP0009278_abnormal_bone_marrow | 1.25729352 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.22195729 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.21497046 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.21374628 |
| 61 | MP0001919_abnormal_reproductive_system | 1.19520007 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.17823731 |
| 63 | MP0000343_altered_response_to | 1.17492198 |
| 64 | MP0010307_abnormal_tumor_latency | 1.15207371 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.14497992 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.11895353 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.11844583 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.08738014 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.08661836 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.08227188 |
| 71 | MP0002254_reproductive_system_inflammat | 1.07664152 |
| 72 | MP0003878_abnormal_ear_physiology | 1.06084873 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 1.06084873 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.04385143 |
| 75 | MP0001873_stomach_inflammation | 0.98939117 |
| 76 | MP0008058_abnormal_DNA_repair | 0.98216953 |
| 77 | MP0009763_increased_sensitivity_to | 0.97115530 |
| 78 | MP0003866_abnormal_defecation | 0.96930636 |
| 79 | MP0001663_abnormal_digestive_system | 0.96884281 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.96746819 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 0.96632587 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 0.96462581 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.92385266 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.89210146 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.88542681 |
| 86 | MP0000313_abnormal_cell_death | 0.86652754 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.86555089 |
| 88 | MP0005647_abnormal_sex_gland | 0.86207570 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.86069835 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.85656156 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.84929124 |
| 92 | MP0002132_abnormal_respiratory_system | 0.82476770 |
| 93 | MP0002933_joint_inflammation | 0.80822885 |
| 94 | MP0003646_muscle_fatigue | 0.79905764 |
| 95 | MP0005023_abnormal_wound_healing | 0.78057050 |
| 96 | MP0005083_abnormal_biliary_tract | 0.76758687 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.76067215 |
| 98 | MP0001764_abnormal_homeostasis | 0.75269999 |
| 99 | MP0003075_altered_response_to | 0.75195981 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.67638920 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.67517125 |
| 102 | MP0000609_abnormal_liver_physiology | 0.66940132 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.66926316 |
| 104 | MP0005451_abnormal_body_composition | 0.66630130 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.66058657 |
| 106 | MP0000598_abnormal_liver_morphology | 0.64739025 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.64364493 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.64153542 |
| 109 | MP0005379_endocrine/exocrine_gland_phen | 0.63646158 |
| 110 | MP0000604_amyloidosis | 0.63423210 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.62943534 |
| 112 | * MP0005390_skeleton_phenotype | 0.62924183 |
| 113 | MP0008932_abnormal_embryonic_tissue | 0.62624102 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.62447450 |
| 115 | MP0005365_abnormal_bile_salt | 0.61830727 |
| 116 | MP0008873_increased_physiological_sensi | 0.61620738 |
| 117 | MP0008874_decreased_physiological_sensi | 0.60767163 |
| 118 | MP0003195_calcinosis | 0.60476801 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.59948483 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.59814316 |
| 121 | MP0001851_eye_inflammation | 0.59542583 |
| 122 | MP0005166_decreased_susceptibility_to | 0.59251169 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.58565736 |
| 124 | MP0003718_maternal_effect | 0.58463797 |
| 125 | MP0008260_abnormal_autophagy | 0.56534503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.99205153 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.54462266 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.26162008 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.96667118 |
| 5 | Increased IgM level (HP:0003496) | 4.81348460 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.73100925 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.73100925 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.73100925 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.44003670 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.33961057 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.28279822 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.22595237 |
| 13 | Stomatitis (HP:0010280) | 4.09788037 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.95214138 |
| 15 | Myositis (HP:0100614) | 3.91798275 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.75857361 |
| 17 | Orchitis (HP:0100796) | 3.60568362 |
| 18 | Vasculitis (HP:0002633) | 3.51551095 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.43082553 |
| 20 | Optic neuritis (HP:0100653) | 3.43082553 |
| 21 | Nasal polyposis (HP:0100582) | 3.33440979 |
| 22 | Recurrent skin infections (HP:0001581) | 3.31064852 |
| 23 | Obstructive lung disease (HP:0006536) | 3.16725632 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16725632 |
| 25 | Recurrent viral infections (HP:0004429) | 3.13783751 |
| 26 | Hypergammaglobulinemia (HP:0010702) | 3.01350992 |
| 27 | Chronic otitis media (HP:0000389) | 2.95181338 |
| 28 | Petechiae (HP:0000967) | 2.91976396 |
| 29 | Gingivitis (HP:0000230) | 2.91326231 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 2.85083228 |
| 31 | Abnormality of T cell number (HP:0011839) | 2.83805721 |
| 32 | Basal ganglia calcification (HP:0002135) | 2.81484945 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.80674920 |
| 34 | Urticaria (HP:0001025) | 2.80126483 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.77554971 |
| 36 | Poor head control (HP:0002421) | 2.77484506 |
| 37 | Leukocytosis (HP:0001974) | 2.75995836 |
| 38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.73983554 |
| 39 | Abnormality of T cells (HP:0002843) | 2.73052105 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 2.70551928 |
| 41 | Pustule (HP:0200039) | 2.68679887 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.68582756 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.66589823 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.66369198 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.65565580 |
| 46 | Thrombocytosis (HP:0001894) | 2.63738646 |
| 47 | Granulocytopenia (HP:0001913) | 2.60865318 |
| 48 | Microretrognathia (HP:0000308) | 2.59464006 |
| 49 | Eosinophilia (HP:0001880) | 2.58791094 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.58347385 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56910607 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56910607 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56560805 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.55531882 |
| 55 | Cellulitis (HP:0100658) | 2.54027965 |
| 56 | Multiple enchondromatosis (HP:0005701) | 2.51052848 |
| 57 | Loss of speech (HP:0002371) | 2.46525835 |
| 58 | Prolonged neonatal jaundice (HP:0006579) | 2.46269294 |
| 59 | Tetraparesis (HP:0002273) | 2.45568983 |
| 60 | Increased serum ferritin (HP:0003281) | 2.40920033 |
| 61 | Cleft eyelid (HP:0000625) | 2.40809046 |
| 62 | Anorexia (HP:0002039) | 2.40063686 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.38876724 |
| 64 | Joint swelling (HP:0001386) | 2.38006784 |
| 65 | Parakeratosis (HP:0001036) | 2.37698238 |
| 66 | Severe visual impairment (HP:0001141) | 2.37173941 |
| 67 | T lymphocytopenia (HP:0005403) | 2.37124557 |
| 68 | Meningitis (HP:0001287) | 2.36962705 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36410577 |
| 70 | Nausea (HP:0002018) | 2.34637786 |
| 71 | Mesangial abnormality (HP:0001966) | 2.34501499 |
| 72 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.32648826 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.28987811 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26098671 |
| 75 | IgG deficiency (HP:0004315) | 2.22514817 |
| 76 | Severe combined immunodeficiency (HP:0004430) | 2.22478013 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.21671277 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.20641457 |
| 79 | Degeneration of anterior horn cells (HP:0002398) | 2.18147866 |
| 80 | Abnormality of the anterior horn cell (HP:0006802) | 2.18147866 |
| 81 | Hemoptysis (HP:0002105) | 2.15387617 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.14435357 |
| 83 | Abnormal number of erythroid precursors (HP:0012131) | 2.12476762 |
| 84 | Lymphopenia (HP:0001888) | 2.12189515 |
| 85 | Hypertensive crisis (HP:0100735) | 2.11552061 |
| 86 | Agnosia (HP:0010524) | 2.10888406 |
| 87 | Purpura (HP:0000979) | 2.08756695 |
| 88 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.08314683 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07689728 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07689728 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07689728 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.05522403 |
| 93 | Porencephaly (HP:0002132) | 2.04164201 |
| 94 | Skin ulcer (HP:0200042) | 2.02114849 |
| 95 | IgA deficiency (HP:0002720) | 2.01464177 |
| 96 | Arterial thrombosis (HP:0004420) | 2.01427804 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01367884 |
| 98 | Lymphoma (HP:0002665) | 2.01078965 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.99731914 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 1.99567928 |
| 101 | Gingival bleeding (HP:0000225) | 1.99245994 |
| 102 | Osteomyelitis (HP:0002754) | 1.98900513 |
| 103 | Cutaneous photosensitivity (HP:0000992) | 1.98396928 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 1.97842642 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96238576 |
| 106 | Periodontitis (HP:0000704) | 1.94933295 |
| 107 | Pallor (HP:0000980) | 1.94067616 |
| 108 | Exertional dyspnea (HP:0002875) | 1.93864463 |
| 109 | Albinism (HP:0001022) | 1.93773646 |
| 110 | Neutropenia (HP:0001875) | 1.92976796 |
| 111 | IgM deficiency (HP:0002850) | 1.92387740 |
| 112 | Increased IgE level (HP:0003212) | 1.92356648 |
| 113 | Acne (HP:0001061) | 1.91106101 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90522805 |
| 115 | Gastrointestinal stroma tumor (HP:0100723) | 1.89406837 |
| 116 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89102917 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.88943765 |
| 118 | Neoplasm of head and neck (HP:0012288) | 1.88117743 |
| 119 | Esophageal neoplasm (HP:0100751) | 1.88117743 |
| 120 | Hypochromic anemia (HP:0001931) | 1.87447166 |
| 121 | Keratoconjunctivitis (HP:0001096) | 1.86240512 |
| 122 | Emphysema (HP:0002097) | 1.85938262 |
| 123 | Gangrene (HP:0100758) | 1.84248995 |
| 124 | Mutism (HP:0002300) | 1.82722348 |
| 125 | Arthralgia (HP:0002829) | 1.82024863 |
| 126 | Abnormality of lateral ventricle (HP:0030047) | 1.81838471 |
| 127 | Encephalitis (HP:0002383) | 1.81596053 |
| 128 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.81350106 |
| 129 | Gastrointestinal inflammation (HP:0004386) | 1.80906737 |
| 130 | Panhypogammaglobulinemia (HP:0003139) | 1.80203175 |
| 131 | Breast hypoplasia (HP:0003187) | 1.79475689 |
| 132 | Axonal loss (HP:0003447) | 1.77424918 |
| 133 | Increased muscle lipid content (HP:0009058) | 1.76813874 |
| 134 | Birth length less than 3rd percentile (HP:0003561) | 1.75933237 |
| 135 | Flat occiput (HP:0005469) | 1.75656305 |
| 136 | Renal Fanconi syndrome (HP:0001994) | 1.72880886 |
| 137 | Colitis (HP:0002583) | 1.68709072 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68347165 |
| 139 | Mucopolysacchariduria (HP:0008155) | 1.68347165 |
| 140 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67211051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.78202016 |
| 2 | TBK1 | 3.56164695 |
| 3 | PIM2 | 3.33219277 |
| 4 | MAP4K1 | 3.29777326 |
| 5 | IRAK3 | 3.01013679 |
| 6 | SMG1 | 2.97405865 |
| 7 | IRAK4 | 2.96753834 |
| 8 | TYK2 | 2.93820655 |
| 9 | IKBKE | 2.63668224 |
| 10 | * IKBKB | 2.61490909 |
| 11 | NME2 | 2.48741195 |
| 12 | BLK | 2.41924478 |
| 13 | ERN1 | 2.35933857 |
| 14 | JAK3 | 2.28699096 |
| 15 | TXK | 2.25869496 |
| 16 | MAP3K11 | 2.12188720 |
| 17 | VRK2 | 2.04040484 |
| 18 | EIF2AK1 | 2.00980218 |
| 19 | PBK | 1.91814539 |
| 20 | RPS6KA4 | 1.89428944 |
| 21 | ZAP70 | 1.88576435 |
| 22 | BUB1 | 1.79483049 |
| 23 | TESK2 | 1.79381013 |
| 24 | TESK1 | 1.76343304 |
| 25 | MST4 | 1.67273884 |
| 26 | * CHUK | 1.66456073 |
| 27 | STK10 | 1.53919214 |
| 28 | MAP2K3 | 1.48865488 |
| 29 | PIM1 | 1.47593506 |
| 30 | ADRBK2 | 1.38552638 |
| 31 | KDR | 1.34575051 |
| 32 | EPHB1 | 1.26151637 |
| 33 | JAK1 | 1.25099396 |
| 34 | RIPK4 | 1.23826201 |
| 35 | MAP2K2 | 1.23776413 |
| 36 | GRK7 | 1.20167180 |
| 37 | BTK | 1.17102053 |
| 38 | IRAK1 | 1.14293537 |
| 39 | SYK | 1.14258673 |
| 40 | KIT | 1.09127699 |
| 41 | DDR2 | 1.08074740 |
| 42 | PLK4 | 1.06719917 |
| 43 | MAP3K10 | 1.01544344 |
| 44 | MAP3K13 | 0.99059532 |
| 45 | ARAF | 0.96309279 |
| 46 | SIK2 | 0.95581763 |
| 47 | FGFR4 | 0.95366038 |
| 48 | LCK | 0.94198958 |
| 49 | MAP3K1 | 0.93918654 |
| 50 | RPS6KA6 | 0.93264611 |
| 51 | HIPK2 | 0.92809121 |
| 52 | STK4 | 0.92114473 |
| 53 | CSK | 0.91761341 |
| 54 | MAP3K3 | 0.91468346 |
| 55 | SIK1 | 0.91455115 |
| 56 | GRK6 | 0.90749146 |
| 57 | SIK3 | 0.88470572 |
| 58 | MAP3K5 | 0.85587838 |
| 59 | RPS6KC1 | 0.85565288 |
| 60 | RPS6KL1 | 0.85565288 |
| 61 | EIF2AK2 | 0.85537628 |
| 62 | EIF2AK3 | 0.84989005 |
| 63 | CDC42BPA | 0.84803329 |
| 64 | MAP3K8 | 0.84437470 |
| 65 | MARK3 | 0.81528860 |
| 66 | LYN | 0.77482615 |
| 67 | CSF1R | 0.76758772 |
| 68 | TAOK2 | 0.76757840 |
| 69 | BMPR2 | 0.75193992 |
| 70 | TEC | 0.72888888 |
| 71 | MAPK11 | 0.72553692 |
| 72 | TLK1 | 0.70355350 |
| 73 | BMX | 0.70008399 |
| 74 | HCK | 0.69764871 |
| 75 | NEK9 | 0.68733110 |
| 76 | PDPK1 | 0.67785715 |
| 77 | WEE1 | 0.66588426 |
| 78 | NLK | 0.66435352 |
| 79 | IRAK2 | 0.65539074 |
| 80 | BRAF | 0.64093951 |
| 81 | LRRK2 | 0.63146989 |
| 82 | MAPKAPK2 | 0.62938237 |
| 83 | NEK2 | 0.62732504 |
| 84 | MAPKAPK3 | 0.62461498 |
| 85 | JAK2 | 0.61830966 |
| 86 | TSSK6 | 0.61562709 |
| 87 | ITK | 0.61072170 |
| 88 | TRIB3 | 0.60052662 |
| 89 | ICK | 0.56615881 |
| 90 | TAF1 | 0.56584857 |
| 91 | RPS6KA5 | 0.56494625 |
| 92 | PAK4 | 0.55975954 |
| 93 | EPHA3 | 0.55843962 |
| 94 | RPS6KA2 | 0.55548756 |
| 95 | CDK12 | 0.55492049 |
| 96 | CDK4 | 0.54460343 |
| 97 | BCKDK | 0.54262892 |
| 98 | FGR | 0.53783107 |
| 99 | TNK2 | 0.53154522 |
| 100 | VRK1 | 0.52838475 |
| 101 | CAMK1D | 0.52418050 |
| 102 | PAK1 | 0.52072777 |
| 103 | TAOK1 | 0.51482098 |
| 104 | FLT3 | 0.50059245 |
| 105 | PDK1 | 0.49880648 |
| 106 | PRKCI | 0.49699264 |
| 107 | TAOK3 | 0.49530245 |
| 108 | CDK7 | 0.48844659 |
| 109 | PRKCD | 0.46996721 |
| 110 | CHEK2 | 0.46360965 |
| 111 | * ABL2 | 0.45916211 |
| 112 | MAP3K9 | 0.45155372 |
| 113 | AURKA | 0.45087429 |
| 114 | RAF1 | 0.44421493 |
| 115 | MOS | 0.43456431 |
| 116 | FES | 0.43033841 |
| 117 | MAPK4 | 0.40501913 |
| 118 | NME1 | 0.39890733 |
| 119 | ZAK | 0.39857794 |
| 120 | ATR | 0.38604608 |
| 121 | ACVR1B | 0.38459799 |
| 122 | DAPK1 | 0.37385703 |
| 123 | * RPS6KA1 | 0.36969691 |
| 124 | MAP2K6 | 0.36177115 |
| 125 | ALK | 0.34468999 |
| 126 | MELK | 0.33974954 |
| 127 | STK16 | 0.32826061 |
| 128 | PLK1 | 0.32422261 |
| 129 | DAPK3 | 0.32038520 |
| 130 | DYRK3 | 0.31490237 |
| 131 | ABL1 | 0.30438589 |
| 132 | MATK | 0.29873474 |
| 133 | EGFR | 0.28372015 |
| 134 | PRPF4B | 0.28369590 |
| 135 | SCYL2 | 0.26509563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.49720421 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20994614 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.93535718 |
| 4 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.85271825 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.57912270 |
| 6 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.49002174 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.35202443 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14117829 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08631056 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08073367 |
| 11 | * Measles_Homo sapiens_hsa05162 | 1.98363294 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.97067698 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.92315631 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.90967697 |
| 15 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86829737 |
| 16 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85537429 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84354862 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81317672 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77978834 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69841671 |
| 21 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.67472707 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67269422 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.58420350 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57395192 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56771855 |
| 26 | * Influenza A_Homo sapiens_hsa05164 | 1.52640571 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.51496214 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.51313539 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49845922 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.49459626 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46995806 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.46391953 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42707747 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.39236363 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34207450 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.30196958 |
| 37 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30042606 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.28658546 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.26977915 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25475260 |
| 41 | * Shigellosis_Homo sapiens_hsa05131 | 1.22913924 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21514577 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21061769 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.18613734 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17414668 |
| 46 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.14842583 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12572820 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 1.11054575 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08559072 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07627103 |
| 51 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05231387 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.04489020 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01029963 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99286368 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99050643 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97048885 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96910184 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96477318 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96357912 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95703151 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95168423 |
| 62 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93812696 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.92579202 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91792338 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.91048678 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86950961 |
| 67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86307623 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84909439 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81500978 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79841421 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76606601 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.76004004 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75017382 |
| 74 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72249074 |
| 75 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70759249 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70548577 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70280354 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.69298267 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65751909 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62842840 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.62567484 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61111455 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59285672 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58435407 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57712270 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56600278 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51249704 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48536376 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.48139908 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47350548 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46929306 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46022884 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45458022 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.44932648 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43039409 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42938260 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42903181 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41587256 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40587526 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.38319381 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38014674 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37244737 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35673939 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35359946 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34706862 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34282642 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34234390 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32892194 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32513315 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32296739 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.31254447 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30832361 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29984869 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.29737236 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27975585 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27669171 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26235903 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25367002 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24432914 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24068148 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.23585987 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22953072 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20302501 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20283369 |

